168 related articles for article (PubMed ID: 17928726)
1. Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients.
Yokoyama K; Sugano N; Shimada T; Shofiqur RA; Ibrahim el-SM; Isoda R; Umeda K; Sa NV; Kodama Y; Ito K
J Oral Sci; 2007 Sep; 49(3):201-6. PubMed ID: 17928726
[TBL] [Abstract][Full Text] [Related]
2. Activity of anti-Porphyromonas gingivalis egg yolk antibody against gingipains in vitro.
Yokoyama K; Sugano N; Rahman AK; Oshikawa M; Ito K
Oral Microbiol Immunol; 2007 Oct; 22(5):352-5. PubMed ID: 17803634
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of lozenges containing egg yolk antibody against Porphyromonas gingivalis gingipains as an adjunct to conventional non-surgical therapy in periodontitis patients: A randomized controlled clinical trial.
Nguyen SV; Nguyen MTH; Tran BC; Ho MTQ; Umeda K; Rahman S
J Periodontol; 2018 Nov; 89(11):1334-1339. PubMed ID: 30043979
[TBL] [Abstract][Full Text] [Related]
4. Egg yolk immunoglobulins' impact on experimental periodontitis caused by Porphyromonas gingivalis.
Wang F; Qiao W; Xu X; Wang S; Regenstein JM; Bao B; Ma M
Technol Health Care; 2018; 26(5):805-814. PubMed ID: 30282381
[TBL] [Abstract][Full Text] [Related]
5. Clinical and microbiological effects of egg yolk antibody against
Xu Y; Selerio-Poely T; Ye X
J Periodontal Implant Sci; 2018 Feb; 48(1):47-59. PubMed ID: 29535890
[TBL] [Abstract][Full Text] [Related]
6. Egg yolk-derived immunoglobulin (IgY) against Porphyromonas gingivalis 40-kDa outer membrane protein inhibits coaggregation activity.
Hamajima S; Maruyama M; Hijiya T; Hatta H; Abiko Y
Arch Oral Biol; 2007 Jul; 52(7):697-704. PubMed ID: 17275778
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Porphyromonas gingivalis proteinase activity by suboptimal doses of antimicrobial agents.
Grenier D; Roy E; Mayrand D
J Periodontol; 2003 Sep; 74(9):1316-9. PubMed ID: 14584864
[TBL] [Abstract][Full Text] [Related]
8. The role of gingipains in the pathogenesis of periodontal disease.
Imamura T
J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
10. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.
Genco CA; Potempa J; Mikolajczyk-Pawlinska J; Travis J
Clin Infect Dis; 1999 Mar; 28(3):456-65. PubMed ID: 10194062
[TBL] [Abstract][Full Text] [Related]
11. Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy.
Fujise O; Hamachi T; Inoue K; Miura M; Maeda K
J Periodontol; 2002 Nov; 73(11):1253-9. PubMed ID: 12479627
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids.
Kariu T; Nakao R; Ikeda T; Nakashima K; Potempa J; Imamura T
J Periodontal Res; 2017 Feb; 52(1):89-96. PubMed ID: 26957413
[TBL] [Abstract][Full Text] [Related]
13. Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.
Palm E; Khalaf H; Bengtsson T
Mol Oral Microbiol; 2015 Feb; 30(1):74-85. PubMed ID: 25055828
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Porphyromonas gingivalis hemagglutinating activity by IgY against a truncated HagA.
Tezuka A; Hamajima S; Hatta H; Abiko Y
J Oral Sci; 2006 Dec; 48(4):227-32. PubMed ID: 17220621
[TBL] [Abstract][Full Text] [Related]
15. A natural anti-periodontitis agent, epimedokoreanin B, inhibits virulence activities of gingipains from
Kariu T; Ikeda T; Nakashima K; Potempa J; Imamura T
Biosci Biotechnol Biochem; 2019 Jul; 83(7):1382-1384. PubMed ID: 30912703
[TBL] [Abstract][Full Text] [Related]
16. The effect of SRP on the clinical and microbiological parameters of periodontal diseases.
Haffajee AD; Cugini MA; Dibart S; Smith C; Kent RL; Socransky SS
J Clin Periodontol; 1997 May; 24(5):324-34. PubMed ID: 9178112
[TBL] [Abstract][Full Text] [Related]
17. Research Note: A novel method for preparation of egg yolk immunoglobulin Y against Porphyromonas gingivalis.
Su H; Wei K; Zhao M; Li X; Zhang Y
Poult Sci; 2023 Sep; 102(9):102863. PubMed ID: 37406435
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II).
Cronan CA; Potempa J; Travis J; Mayo JA
Oral Microbiol Immunol; 2006 Aug; 21(4):212-7. PubMed ID: 16842504
[TBL] [Abstract][Full Text] [Related]
19. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population II--microbiological results.
Carvalho LH; D'Avila GB; Leão A; Gonçalves C; Haffajee AD; Socransky SS; Feres M
J Clin Periodontol; 2005 Apr; 32(4):406-11. PubMed ID: 15811059
[TBL] [Abstract][Full Text] [Related]
20. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis.
Moritz AJ; Cappelli D; Lantz MS; Holt SC; Ebersole JL
J Periodontol; 1998 Jun; 69(6):686-97. PubMed ID: 9660338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
